The symposium provided a forum for discussion of current clinical research issues and the problem of risk/benefit analysis for the use of three important classes of cardiovascular agents. Seventeen contributions. No index. No bibliography. Annotation copyright Book News, Inc. Portland, Or.
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Fri frakt for privatpersoner. Sendes innen 2‑5 virkedager.